- Home
- NRO vs RCEL Comparison
NRO vs RCEL Comparison
Compare NRO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- RCEL
- Stock Information
- Founded
- NRO 2003
- RCEL N/A
- Country
- NRO United States
- RCEL United States
- Employees
- NRO N/A
- RCEL N/A
- Industry
- NRO Finance/Investors Services
- RCEL Medical/Dental Instruments
- Sector
- NRO Finance
- RCEL Health Care
- Exchange
- NRO Nasdaq
- RCEL Nasdaq
- Market Cap
- NRO 156.7M
- RCEL 161.5M
- IPO Year
- NRO N/A
- RCEL N/A
- Fundamental
- Price
- NRO $3.27
- RCEL $5.42
- Analyst Decision
- NRO
- RCEL Strong Buy
- Analyst Count
- NRO 0
- RCEL 4
- Target Price
- NRO N/A
- RCEL $16.50
- AVG Volume (30 Days)
- NRO 239.4K
- RCEL 316.4K
- Earning Date
- NRO 01-01-0001
- RCEL 08-07-2025
- Dividend Yield
- NRO 11.41%
- RCEL N/A
- EPS Growth
- NRO N/A
- RCEL N/A
- EPS
- NRO N/A
- RCEL N/A
- Revenue
- NRO N/A
- RCEL $71,661,000.00
- Revenue This Year
- NRO N/A
- RCEL $57.16
- Revenue Next Year
- NRO N/A
- RCEL $36.69
- P/E Ratio
- NRO N/A
- RCEL N/A
- Revenue Growth
- NRO N/A
- RCEL 41.35
- 52 Week Low
- NRO $2.51
- RCEL $4.71
- 52 Week High
- NRO $3.45
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- NRO 55.93
- RCEL 43.61
- Support Level
- NRO $3.19
- RCEL $5.11
- Resistance Level
- NRO $3.27
- RCEL $5.55
- Average True Range (ATR)
- NRO 0.04
- RCEL 0.31
- MACD
- NRO 0.00
- RCEL 0.10
- Stochastic Oscillator
- NRO 86.08
- RCEL 69.61
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.